Skip to main content
Premium Trial:

Request an Annual Quote

Boston Children's Coronavirus Test Gets Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for a PCR-based SARS-CoV-2 test developed by Boston Children's Hospital.

The Childrens-Altona-SARS-CoV-2 assay is designed to detect one target sequence of the SARS-CoV-2 spike glycoprotein gene in nasopharyngeal, oropharyngeal, nasopharyngeal/ oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens. The test is used with Qiagen's Virus MinElute Spin viral RNA/DNA purification kit performed on the QiaCube extraction platform, the company's Qiagility automated PCR setup instrument with software version 4.17.1, and its Rotor-Gene Q 5Plex instrument with software version 2.3.1.

According to the FDA, the test is to be performed at Boston Children's infectious diseases diagnostics laboratory.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.